🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

23+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 20 of 23 recruiting trials for “western-equine-encephalitis

RecruitingNCT07332234

Optic Nerve Ultrasound for Assessing Cerebral Inflammation and Intracranial Hypertension in Cerebral Pathologies

👨‍⚕️ Bogdan Pavel, MD, PhD, DESA, "Dr. Victor Babeș" Clinical Hospital for Infectious and Tropical Diseases📍 2 sites📅 Started Dec 2025View details ↗
NARecruitingNCT07158229

Long-term Impact of NMDAR Encephalitis, Level 3

👨‍⚕️ Jérôme HONNORAT, Pr📍 1 site📅 Started Nov 2025View details ↗
RecruitingNCT07477015

Study of Pathogenic Mechanisms and Identification of Novel Autoantibodies in Autoimmune Encephalitis

👨‍⚕️ Raffaele Iorio, Fondazione Policlinico Universitario A. Gemelli, IRCCS📍 1 site📅 Started Jul 2025View details ↗
Phase 1, PHASE2RecruitingNCT06680128

A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy Adults

🏥 SK Bioscience Co., Ltd.📍 3 sites📅 Started Feb 2025View details ↗
RecruitingNCT06368648

CoMind Early Feasibility Study

👨‍⚕️ Ramani Balu, MD, PhD, Inova Fairfax Hospital📍 14 sites📅 Started Nov 2024View details ↗
Phase 3RecruitingNCT06867991

Safety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune Encephalitis

🏥 The First People's Hospital of Changzhou📍 2 sites📅 Started Nov 2024View details ↗
NARecruitingNCT06584045

Efficacy and Safety of Calculus Bovis Sativus (CBS) for Adult Encephalitis (CBSinEncephalitis)

🏥 Tongji Hospital📍 1 site📅 Started Sep 2024View details ↗
RecruitingNCT07133113

Medium-term Effects of Treatments in Autoimmune Encephalitis

🏥 Hospices Civils de Lyon📍 1 site📅 Started Sep 2024View details ↗
Phase 2RecruitingNCT06510426

Early Interferon-beta Treatment for West-Nile Virus Infection

🏥 Tel-Aviv Sourasky Medical Center📍 1 site📅 Started Jul 2024View details ↗
RecruitingNCT07191223

Evaluation of Knowledge on Tick-borne Encephalitis Virus (TBEV) Infection Among General Practitioners in France

🏥 University Hospital, Strasbourg, France📍 1 site📅 Started Feb 2024View details ↗
RecruitingNCT07251049

Acute Infectious Encephalitis and Myelitis in Guadeloupe by New Generation Sequencing

👨‍⚕️ Hugo CHAUMONT, Doctor, CHU de la Guadeloupe📍 1 site📅 Started Nov 2023View details ↗
Phase 1, PHASE2RecruitingNCT05586581

SV2A & TSPO PET Imaging Measures to Reveal Mechanisms of HIV Neuropathogenesis During Antiretroviral Therapy

👨‍⚕️ Serena Spudich, MD, Yale University📍 1 site📅 Started May 2023View details ↗
RecruitingNCT06019975

FDG-PET in the Diagnosis of Autoimmune Encephalitis

👨‍⚕️ Simone Beretta, MD, PhD, University of Milano Bicocca📍 6 sites📅 Started Mar 2023View details ↗
Phase 3RecruitingNCT05503264

A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis

👨‍⚕️ Clinical Trials, Hoffmann-La Roche📍 92 sites📅 Started Sep 2022View details ↗
Enrolling by InvitationNCT07186881

Evolving Diagnostic Approaches to Undocumented Lymphocytic Meningitis and Meningoencephalitis

🏥 Central Hospital, Nancy, France📍 1 site📅 Started Aug 2022View details ↗
NARecruitingNCT05198661

Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis Collection

🏥 Hospices Civils de Lyon📍 62 sites📅 Started Aug 2022View details ↗
RecruitingNCT06173076

A Prospective Study to Evaluate Clinical Outcomes in Anti-LGI1 Encephalitis

👨‍⚕️ Chun-Hong Shen, 2nd Affiliated Hospital, School of Medicine, Zhejiang University, China📍 1 site📅 Started May 2022View details ↗
Phase 2RecruitingNCT04372615

The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis

👨‍⚕️ Stacey L Clardy, MD, PhD, University of Utah📍 20 sites📅 Started Mar 2022View details ↗
RecruitingNCT05772611

Characterization of Immune-response in Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes

🏥 Hospices Civils de Lyon📍 1 site📅 Started Feb 2022View details ↗
Phase 2RecruitingNCT03993262

Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis

👨‍⚕️ Christian Geis, Prof., University Hospital Jena📍 17 sites📅 Started May 2020View details ↗
Page 1 of 2Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →